President Donald Trump unwrapped a massive drug pricing policy as CMS prepares for the next round of Medicare drug price negotiations; Vinay Prasad to take the helm at the FDA’s Center for Biologics ...

The drive revolves around a "10-for-one" policy laid out in a Trump executive order at the end of January, which demanded ...

It also ties into the UK's ambition to harness health data for medical research, backed by a £600 million ($764 million) investment by the government announced last month. "AI models are only as ...

It seems Eisai and Biogen have another hurdle to jump over in their bid to get EU approval for their Alzheimer's disease therapy Leqembi. In the latest development, the European Commission has ...

In 1917, Professor Arthur Stoll created Sandoz's pharmaceutical department and research began. A year later, Stoll isolated ergotamine from ergot and the substance went on to treat migraine headaches.

It has previously signed a bi-specific immune-oncology antibody deal with China’s EpimAb and had begun early research with The Scripps Research Institute in California about a potential new ...

Several key factors fuel the need for new, high-tech production facilities. Rising investment in research and development within biotech has intensified demand for specialised production ...

The FDA has issued a complete response letter (CRL) to Merck & Co's gefapixant candidate for refractory chronic cough, delaying the programme and giving Bayer an opportunity to close the gap with ...

"We are immensely thankful for the dedication to innovative research that has led to this approval, and we are ready to help families embark on this new chapter of treatment." In a statement ...

Ablynx is looking for new partners to take its rheumatoid arthritis drug vobarilizumab into phase 3 development, after AbbVie turned down an option to license the drug. AbbVie has already paid the ...

A multibillion-dollar partnership between AbbVie and Genmab risks being soured by a lawsuit claiming misappropriation of trade secrets. Specifically, it focuses on the use of disaccharides to ...

With vaccine hesitancy leading to a rise in measles cases, the FDA's approval of GlaxoSmithKline's venerable vaccine Priorix for sale in the US looks timely. Priorix was first launched in Europe ...